Tampa, FL – (September 23, 2017) – LifeLink Tissue Bank, a division of LifeLink Foundation, Inc. headquartered in Tampa, FL, announced a new partnership with Taiwan-based HCT Regenerative, in which LifeLink will provide allografts for patients suffering from sports, orthopedic and/or spine injuries.
HCT Regenerative was established in July 2016, and is the first company in Taiwan to focus on processing human tissue to produce regenerative biomaterials for clinical use. LifeLink will procure and provide to HCT certain bone and tissue for HCT’s use in its operations, while both parties will collaborate to assist HCT in the growth and development of its operations.
Jean Davis, President and CEO of LifeLink Foundation, Inc. said, “LifeLink is pleased to work with HCT Regenerative, which will provide tissue for reconstructive procedures to save and heal lives, and increase donation opportunities for donors and their families. This is a great opportunity for LifeLink to make an impact in Taiwan and across Asia.”
James Tsai, Ph.D., HCT cofounder and Managing Director, said, “It is a great honor to partner with LifeLink Foundation. Together we are dedicated to providing high quality allografts to improve patients’ quality of life in the Asia-Pacific region.”
LifeLink Foundation, an independent, non-profit community service organization is dedicated to the recovery and transplantation of organs and tissue. The Foundation is made up of five divisions: LifeLink Tissue Bank, which recovers and processes tissue for patients in need, LifeLink of Florida, LifeLink of Georgia, and LifeLink of Puerto Rico, three federally-certified organ procurement organizations; and LifeLink Transplantation Immunology Laboratory, which supports 15 organ-specific transplant programs. Additionally, the LifeLink Legacy Fund supports the LifeLink Foundation mission through transplant patient assistance, research and programmatic grants to improve organ and tissue donation, and transplantation. Learn more about LifeLink Foundation at www.LifeLinkFoundation.org, or LifeLink Tissue Bank at www.LifeLinkTB.org.
About HCT Regenerative:
HCT Regenerative is devoted to developing advanced human cellular and tissue based products (HCT/Ps) to improve patients' quality of life. The company aims to cultivate relationships with American tissue banks as well as hospitals and medical device companies in Taiwan to help achieve the goals. Additionally, HCT Regenerative will develop and manufacture high quality tissue allografts for surgeons throughout the Taiwanese market to benefit patients in need. For more information visit www.HCTRegenerative.com.